BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 9869018)

  • 21. Dose-response effect of the lercanidipine/enalapril combination: a pooled analysis.
    Rizzoni D
    Curr Med Res Opin; 2016 Oct; 32(sup2):17-23. PubMed ID: 27779458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losartan potassium lowers blood pressure measured by ambulatory blood pressure monitoring.
    Byyny RL
    J Hypertens Suppl; 1995 Jul; 13(1):S29-33. PubMed ID: 18800453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group.
    Zannad F; Bernaud CM; Fay R
    J Hypertens; 1999 Jan; 17(1):137-46. PubMed ID: 10100105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the calcium antagonist benidipine hydrochloride on 24-h ambulatory blood pressure in patients with mild to moderate hypertension in a double-blind study against placebo.
    Nakajima O; Akioka H; Miyazaki M
    Arzneimittelforschung; 2000 Jul; 50(7):620-5. PubMed ID: 10965418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-four-hour ambulatory blood pressure evaluation of antihypertensive agents.
    Zanchetti A
    J Hypertens Suppl; 1997 Dec; 15(7):S21-5. PubMed ID: 9532517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new approach to assessing antihypertensive therapy: effect of treatment on pulse pressure. Candesartan cilexetil in Hypertension Ambulatory Measurement of Blood Pressure (CHAMP) Study Investigators.
    Asmar R; Lacourcière Y
    J Hypertens; 2000 Nov; 18(11):1683-90. PubMed ID: 11081784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly.
    Wing LM; Arnolda LF; Harvey PJ; Upton J; Molloy D; Bune AJ; Chalmers JP
    J Hypertens; 1997 Dec; 15(12 Pt 1):1503-10. PubMed ID: 9431858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group.
    Zannad F; Boivin JM
    J Hypertens; 1999 Jul; 17(7):1023-32. PubMed ID: 10419077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS; Malakos JS; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):412-6. PubMed ID: 9125681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T; Himmelmann A
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.
    Mugellini A; Vaccarella A; Celentano A; Scanferla F; Zoppi A; Fogari R
    Blood Press Suppl; 2005 Jul; 1():6-13. PubMed ID: 16060411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients.
    Mancia G; Omboni S; Agabiti-Rosei E; Casati R; Fogari R; Leonetti G; Montemurro G; Nami R; Pessina AC; Pirrelli A; Zanchetti A
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):926-31. PubMed ID: 10836728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of lercanidipine/enalapril versus amlodipine/enalapril and hydrochlorothiazide/enalapril on target organ damage and sympathetic activation in non-obese essential hypertensive subjects.
    Tsioufis K; Tsioufis C; Dimitriadis K; Mantzouranis E; Mani I; Tousoulis D
    Curr Med Res Opin; 2016 Oct; 32(sup2):35-41. PubMed ID: 27779461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.